IL6R and Ventricular arrhythmia: As shown in Figure 7C, QT interval is increased by +36% and +53% (Table 4), for IL-6 and IL-6 + IL-6R, respectively, consistent with the signature high risk proarrhythmic effect that underlie fatal ventricular arrhythmias in patients.